Variant report
Variant | esv3388330 |
---|---|
Chromosome Location | chr5:106231103-106233251 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549185986 | chr5:106231109-106231110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559930770 | chr5:106231138-106231139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142265453 | chr5:106231147-106231148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368146039 | chr5:106231167-106231168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188420761 | chr5:106231177-106231178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537707368 | chr5:106231191-106231192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550617937 | chr5:106231192-106231193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201372774 | chr5:106231207-106231208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368093036 | chr5:106231210-106231211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567251317 | chr5:106231216-106231217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181579497 | chr5:106231225-106231226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552786486 | chr5:106231265-106231266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185688252 | chr5:106231322-106231323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538456363 | chr5:106231325-106231326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558676005 | chr5:106231366-106231367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575184371 | chr5:106231422-106231423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544071721 | chr5:106231457-106231458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147469123 | chr5:106231503-106231504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563368831 | chr5:106231543-106231544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544725536 | chr5:106231551-106231552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73204113 | chr5:106231575-106231576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs75108170 | chr5:106231593-106231594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1909743 | chr5:106231645-106231646 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs559299356 | chr5:106231652-106231653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528545308 | chr5:106231653-106231654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565177949 | chr5:106231669-106231670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75737533 | chr5:106231711-106231712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1909744 | chr5:106231716-106231717 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs531262138 | chr5:106231720-106231721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140072123 | chr5:106231738-106231739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139874990 | chr5:106231779-106231780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2964615 | chr5:106231786-106231787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs535549154 | chr5:106231791-106231792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535870310 | chr5:106231806-106231807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373036175 | chr5:106231831-106231832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201581665 | chr5:106231835-106231836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs397951939 | chr5:106231843-106231844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs28495553 | chr5:106231844-106231845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs28698817 | chr5:106231846-106231847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374886134 | chr5:106231869-106231870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566450279 | chr5:106231909-106231910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs202178812 | chr5:106231910-106231911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200310706 | chr5:106231912-106231913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147854356 | chr5:106231924-106231925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs72005598 | chr5:106231938-106231939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376312697 | chr5:106231948-106231949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370389985 | chr5:106231949-106231950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530835630 | chr5:106231957-106231958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs13153296 | chr5:106231960-106231961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543699078 | chr5:106231962-106231963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:106230200-106231400 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr5:106230200-106231400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr5:106230600-106231400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr5:106230800-106231200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr5:106231400-106233400 | Weak transcription | Primary monocytes fromperipheralblood | blood |